Abstract:Background: Chronic alcohol consumption impairs gut barrier function and perturbs the gut microbiome. Although shifts in bacterial communities in patients with alcohol-associated liver disease (ALD) have been characterized, less is known about the interactions between host metabolism and circulating microbe-derived metabolites during the progression of ALD. Methods: A large panel of gut microbiome-derived metabolites of aromatic amino acids was quantified by stable isotope dilution liquid chromatography with online tandem mass spectrometry in plasma from healthy controls (n = 29), heavy drinkers (n = 10), patients with moderate (n = 16) or severe alcohol-associated hepatitis (n = 40), and alcohol-associated cirrhosis (n = 10). Results: The tryptophan metabolites, serotonin and indole-3-propionic acid, and tyrosine metabolites, p-cresol sulfate, and p-cresol glucuronide, were decreased in patients with ALD. Patients with severe alcohol-associated hepatitis and alcohol-associated cirrhosis had the largest decrease in concentrations of tryptophan and tyrosine-derived metabolites compared to healthy control. Western blot analysis and interrogation of bulk RNA sequencing data from patients with various liver pathologies revealed perturbations in hepatic expression of phase II metabolism enzymes involved in sulfonation and glucuronidation in patients with severe forms of ALD. Conclusions: We identified several metabolites decreased in ALD and disruptions of hepatic phase II metabolism. These results indicate that patients with more advanced stages of ALD, including severe alcohol-associated hepatitis and alcohol-associated cirrhosis, had complex perturbations in metabolite concentrations that likely reflect both changes in the composition of the gut microbiome community and the ability of the host to enzymatically modify the gut-derived metabolites.

Alcohol effects on hepatic lipid metabolism

Alcohol and the mechanisms of liver disease

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

Noncoding RNAs in Alcoholic Liver Disease

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

A review on molecular mechanism of alcoholic liver disease

Alcoholic Hepatitis: A Review

Alcoholic liver disease: a new insight into the pathogenesis of liver disease

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis

Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy

Alcohol or Gut Microbiota: Who Is the Guilty?

Alcohol-associated liver disease - a current overview

Alcohol and Hepatocellular Carcinoma

Effects of Flavonoids on Alcoholic Liver Disease: A Review

Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases

Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review

Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease

Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD